InvestorsObserver
×
News Home

Should You Buy Surgalign Holdings Inc (SRGA) Stock on Thursday?

Thursday, December 31, 2020 11:15 AM | InvestorsObserver Analysts

Mentioned in this article

Surgalign Holdings Inc (SRGA) stock is down 20.08% over the past week and gets a Bearish rating from InvestorsObserver's Sentiment Indicator.

Sentiment Score - ,bearish
Surgalign Holdings Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on SRGA!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With SRGA Stock Today?

Surgalign Holdings Inc (SRGA) stock is lower by -5.68% while the S&P 500 has gained 0.01% as of 11:12 AM on Thursday, Dec 31. SRGA is lower by -$0.13 from the previous closing price of $2.24 on volume of 429,756 shares. Over the past year the S&P 500 has risen 15.52% while SRGA is lower by -22.99%. SRGA lost -$1.73 per share in the over the last 12 months.

To screen for more stocks like Surgalign Holdings Inc click here.

More About Surgalign Holdings Inc

Surgalign Holdings Inc is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.

Click Here to get the full Stock Score Report on Surgalign Holdings Inc (SRGA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App